The Alzheimer’s Disease Clinical Spectrum: Diagnosis and Management
Keywords
Cited by (0)
-
Disclosure Statement: Dr. Atri has no equity, shares or salary from any pharma company and is not a member of any pharma speakers’ bureau. He has received honoraria for consulting, educational lectures/programs/materials or advisory boards from AbbVie, Allergan, Alzheimer’s Association, Biogen, Eisai, Grifols, Harvard Medical School Graduate Continuing Education, Lundbeck, Merck, Oxford University Press (medical book-related revenues), Sunovion, Suven, and Synexus. Dr. Atri’s institution (Banner Health) has investigational observational study/trial related funding from Novartis. Dr. Atri’s previous institution (California Pacific Medical Center) had contracts or received investigational clinical trial related funding from The American College of Radiology, AbbVie, Avid, Biogen, Lilly, Lundbeck, Merck, and vTV.